Simplifying clinical use of the genetic risk prediction model BRCAPRO

Breast Cancer Research and Treatment

Volumn 139, Issue 2, 2013, Pages 571-579

  Biswas, Swati ^a   Atienza, Philamer ^b,c   Chipman, Jonathan ^d   Hughes, Kevin ^e   Barrera, Angelica M Gutierrez ^f   Amos, Christopher I ^g   Arun, Banu ^f   Parmigiani, Giovanni ^d,h  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c ALCON RESEARCH LTD   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g DARTMOUTH MEDICAL SCHOOL   (United States)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

BRCA1; BRCA2; BRCAPRO; CancerGene; FHAT; Genetic counseling; Genetic risk; HughesRiskApps

Indexed keywords

ARTICLE; CALIBRATION; CONTROLLED STUDY; DATA ANALYSIS; GENETIC MODEL; GENETIC RISK; INTERMETHOD COMPARISON; PEDIGREE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INTERNET; MALE; MEDICAL INFORMATICS; MUTATION; OVARIAN NEOPLASMS; RISK; SOFTWARE;

EID: 84878751614     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2564-4     Document Type: Article

References (19)

1. Antoniou A, Pharoah PD, Narod S, et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130
2. King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646
3. Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ; Consensus Conference Committee The International Consensus Conference Committee. (2008) Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Cancer 113:2627-2637
4. Drohan B, Roche CA, Cusack JC, Hughes KS (2012) Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol 19:1732-1737
5. Drohan B, Ozanne EM, Hughes KS (2009) Electronic health records and the management of women at high risk of hereditary breast and ovarian cancer. Breast J 15(Suppl 1):46-55
6. Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145-158
7. Chen S, Wang W, Broman KW, et al (2004) BayesMendel: an R environment for Mendelian risk prediction. Stat Appl Genet Mol Biol 3:Article21
8. Tai YC, Chen S, Parmigiani G, et al (2008) Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction. Breast Cancer Res 10:401
9. Katki HA, Blackford A, Chen S, et al (2008) Multiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO. Stat Med 27:4532-4548
10. Katki HA (2007) Incorporating medical interventions into Mendelian mutation prediction models. BMC Med Genet 8:13
11. Chen S, Blackford AL, Parmigiani G (2009) Tailoring BRCAPRO to Asian-Americans. J Clin Oncol 27:642-643
12. Biswas S, Tankhiwale N, Blackford A, et al (2012) Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO. Breast Cancer Res Treat 133:347-355
13. Ozanne EM, Loberg A, Hughes S, et al (2009) Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. Breast J 15:155-162
14. Gilpin CA, Carson N, Hunter AG (2000) A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center. Clin Genet 58:299-308
15. Parmigiani G, Chen S, Iversen ES, et al (2007) Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 147:441-450
16. Chen S, Wang W, Lee S, et al (2006) Prediction of germline mutations and cancer risk in the Lynch syndrome. J Am Med Assoc 296:1479-1487
17. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157-172
18. Efron B, Tibshirani R (1994) An introduction to the bootstrap. Chapman and Hall/CRC, Boca Raton
19. Parmigiani G (2002) Modeling in medical decision making: a Bayesian approach. Wiley, Chichester